» Authors » Nithin Reddy

Nithin Reddy

Explore the profile of Nithin Reddy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 49
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zipper R, Fong V, Toker M, Reddy N, Srivastava P, Amin B, et al.
Am J Hematol . 2022 Sep; 97(12):1654-1658. PMID: 36112359
No abstract available.
2.
Werth V, Hejazi E, Pena S, Haber J, Zeidi M, Reddy N, et al.
J Invest Dermatol . 2022 May; 142(10):2651-2659.e1. PMID: 35490744
Background: Treatment options are limited for skin disease in dermatomyositis. Lenabasum is a cannabinoid receptor type 2 agonist that triggers the resolution of inflammation. Objective: The objective of this study...
3.
Maddukuri S, Patel J, Diaz D, Chen K, Wysocka M, Bax C, et al.
Arthritis Res Ther . 2022 Mar; 24(1):69. PMID: 35277198
No abstract available.
4.
Deutsch A, Reddy N, McLellan B, Shinoda K
J Invest Dermatol . 2022 Mar; 142(9):2518-2521.e2. PMID: 35271854
No abstract available.
5.
Maddukuri S, Patel J, Diaz D, Chen K, Wysocka M, Bax C, et al.
Arthritis Res Ther . 2022 Jan; 24(1):12. PMID: 34983619
Background: Lenabasum is a cannabinoid type 2 receptor (CB2R) reverse agonist that demonstrates anti-inflammatory effects in vivo and in vitro in dermatomyositis (DM) and is currently being investigated for therapeutic...
6.
Schwimmer L, Huang B, Giang H, Cotter R, Chemla-Vogel D, Dy F, et al.
J Immunol Methods . 2013 Mar; 391(1-2):60-71. PMID: 23454004
Phage display antibody libraries have a proven track record for the discovery of therapeutic human antibodies, increasing the demand for large and diverse phage antibody libraries for the discovery of...